The clinical and cost-effectiveness of interventions for preventing continence issues resulting from birth trauma: a rapid review

1.1 Who is this review for?

This Rapid Review was conducted as part of the Health and Care Research Wales Evidence Centre Work Programme. The review question was suggested by representatives from the Women’s Health Department of the Welsh Government. The intended audience is Women’s Health and continence service commissioners and policy makers in Wales. This research will be used to guide policy recommendations regarding provisions for continence care in Wales.

1.2 Background and purpose of this review

Often linked to the stresses and strains of childbirth, particularly perineal trauma, incontinence is a debilitating condition that can significantly impact women’s quality of life. Perineal trauma and other injuries to this area can weaken pelvic floor muscles resulting in the development of incontinence following childbirth.

Approximately 450,000 women who give birth vaginally each year in the UK suffer some form of childbirth-related perineal trauma. This represents approximately 80% of all vaginal deliveries, either spontaneously, or as a result of an episiotomy (NHS Digital, 2019). Perineal trauma is defined as any damage to the area between the vagina and the anus during childbirth. The severity of trauma is categorised as follows: first-degree (small tears affecting skin that heal without treatment), second-degree (tears affecting perineal muscle typically requiring stitches) and third and fourth-degree tears (deeper tears, also known as obstetric anal sphincter tears, that need to be operated on) (Royal College of Obstetricians and Gynaecologists, n.d.). Third and fourth-degree tears occur in approximately 3% of all vaginal births and 6% of first-time vaginal births in the UK (Royal College of Obstetricians and Gynaecologists, 2015).

The prevalence of perineal trauma varies by mode of delivery. Up to 85% of women who deliver vaginally sustain a form of perineal trauma (NHS Digital, 2019; Smith et al., 2013; Brandie & MacKenzie, 2009). The prevalence of perineal trauma in first time vaginal births (primipara) is estimated to be higher, affecting 91% of women (Smith et al., 2013). Within vaginal births, delivery with instruments (approximately 60 per 1000 deliveries) results in greater incidence of perineal trauma compared to vaginal delivery without instruments (approximately 29 per 1000) (Orlovic et al., 2017). Maternal age, existing maternal medical conditions and a history of complicated deliveries were identified as primary risk factors for perineal trauma (Orlovic et al., 2017).

Incontinence, defined as the accidental loss or leaking of urine, faeces or gas is one of several commonly reported sequelae in women following childbirth. Incontinence can be a significantly debilitating issue in the first year after giving birth (Grant & Currie, 2020; Sobhgol et al., 2022). Estimates from worldwide literature on the incidence of post-partum incontinence in women who delivered vaginally range from 31% to 47% (Moossdorff- Steinhauser et al., 2021; Moran et al., 2020; Thom & Rortveit, 2010).

Urinary incontinence is a devastating condition that can impact women at any stage of the life-course, but is highly prevalent among middle-aged and postmenopausal women, yet it remains a widely underreported issue as many women suffer in silence due to embarrassment or a lack of awareness of treatment options.

Pregnancy and childbirth can weaken the pelvic floor, making women more susceptible to incontinence in later life (NICE, 2021a). Menopause often exacerbates these issues due to hormonal changes and by further weakening the pelvic floor muscles (Menezes et al., 2010). Obstetric trauma from vaginal delivery resulting in irreversible traumatic lesions to the urinary continence system is also a known link to incontinence in later life (Fritel et al., 2012).

The exact prevalence of urinary incontinence among the whole population of women in the UK is varied depending on the definition and methodology of incontinence reported in sources; however, it is estimated that urinary incontinence affects between 20-50% of women, but the prevalence is greater among women who have given birth and in older women (Hannestad et al., 2000; Hunskaar et al., 2004). More recently, a cross-sectional survey of 1,415 women reported a 40% prevalence of urinary incontinence among women in the UK (Cooper et al., 2015). Incontinence (faecal, urinary and gas) are all conditions that reduce quality of life and incur significant costs to both patients and the healthcare system. Implementing preventative interventions targeting incontinence following childbirth has the potential to reduce associated healthcare and wider societal costs. The economic burden of birth trauma and incontinence is presented in section 1.3 of this report.

The initial research question concerned the economic impact of birth trauma. However, following discussions with the stakeholders, the subsequent review question evolved to focus on the cost-effectiveness of interventions to prevent continence issues after birth trauma (or giving birth). The interventions considered were any intervention aiming to prevent continence issues following childbirth.

Preliminary literature searches identified very few economic evaluations of interventions to prevent continence issues following childbirth. To supplement the lack of economic evidence, the scope of the searches for this rapid review was broadened to include evidence from systematic reviews on the clinical effectiveness of interventions to prevent continence issues following childbirth. A separate targeted search of studies reporting economic burden of illness was also conducted to present the economic argument for investing in interventions that have been found to be clinically effective (section 1.3). To further set this review within the relevant UK policy and practice landscape, a presentation of relevant National Institute for Health and Care Excellence (NICE) guidance is presented in section 1.4.

The aim of this rapid review was to present evidence on the clinical effectiveness and cost- effectiveness of interventions to prevent continence issues resulting from birth trauma. The rapid review question was:What is the clinical effectiveness and cost-effectiveness of interventions for preventing continence issues resulting from birth trauma?

Results from the rapid review search are presented throughout section 2 and grouped by intervention type.

1.3 The economic burden of birth trauma and incontinence

A recent UK Government report highlighted the lack of research on the economic cost of birth trauma (The All-Party Parliamentary Group on Birth Trauma, 2024). Identified evidence from the supplementary searches of economic burden focussed on the more immediate costs of perineal trauma (healthcare costs of treating these conditions immediately following delivery). There was no identified evidence on costs and consequences of incontinence following childbirth. However, issues such as psychological distress and trauma following a difficult birth have been found to have long-lasting impacts and cost society £8.1 billion per annum in the UK (Bauer, Tinelli & Knapp, 2022).

The considerable proportion of women who deliver vaginally each year in the UK suffering some form of perineal trauma (80% of all vaginal deliveries) results in increased healthcare costs as mothers are required to remain in hospital for longer to undergo non-elective short- stay procedures. In England, childbirth-related obstetric trauma caused by vaginal delivery is estimated to add an additional 0.5 bed days to patient length of stay post-delivery, before being discharged (Orlovic et al., 2017). The total cost of these additional bed days attributed to obstetric patient safety events was £14.5 million in 2013/2014. Inflated to June 2024 prices*, this figure is now £19.5 million. The average unit cost of non-elective inpatient short- stay following childbirth (in the NHS) in 2013/14 was calculated to be £1,279. Inflating to June 2024* prices, this rises to £1,714 per patient stay (Orlovic et al., 2017). Unit costs represent all healthcare resources used in providing one average short-term inpatient stay targeting and treating obstetric trauma following childbirth.

The delivery method with the highest associated costs is vaginal delivery without instrument. This delivery method results in fewer perineal trauma events than instrument-assisted delivery, yet the volume of unassisted deliveries drives this increase in costs (Orlovic et al., 2017). This finding is supported by the findings of Okeahialam and colleagues (Okeahialam, Sultan & Thakar, 2022).

Obstetric trauma following childbirth affects a substantial number of mothers each year in the UK, and its treatment places excess pressure on the NHS. In 2013/14, the economic burden of all birth-related obstetrical anal sphincter injuries in the UK ranged between £3.7 million (in assisted vaginal births) and £9.8 million (in spontaneous vaginal births) (Orlovic et al., 2017). Inflated to June 2024 prices*, these figures are £4.9 million and £13.1 million, respectively. From a wider perspective, £3.1 billion was awarded in patient legal damage claims against perineal trauma between 2002 and 2012. It was the fourth leading cause of claims in obstetrics (Steen & Diaz, 2018).

Incontinence, the involuntary loss of urine or faeces can be a significant complication of perineal trauma and childbirth more generally. The economic cost of incontinence on both individuals and the healthcare system is substantial (Javanbakht et al., 2020). Costs arise from various sources, including direct healthcare costs, patient out-of-pocket expenses for incontinence products and wider societal costs such as lost productivity due to absenteeism or reduced work performance (Fultz et al., 2005). A previous study utilising data from three European countries estimated that the total cost of stress urinary incontinence in the UK is approximately £818 million (Papanicolaou et al., 2005). A separate study reported a cost of £118million per year to the NHS in healthcare costs for stress urinary incontinence (Turner et al., 2004).

The prevention of birth trauma and subsequent urinary and faecal incontinence could facilitate immediate cost savings to the healthcare system by reducing time spent in hospital after birth. Interventions to prevent incontinence following childbirth will also yield substantial long-term savings through decreased health and care resource utilisation. Cost-savings from incontinence prevention from a wider societal perspective may be manifested through reduced absenteeism and improved productivity among affected workers.

1.4 NICE guidance on perineal care

This section summarises the National Institute for Health and Care Excellence (NICE) 2021 guidance (NG210) on the prevention and non-surgical management of pelvic floor dysfunction (NICE, 2021a) and the NICE 2007 guidance (CG49) on faecal incontinence management in adults (NICE, 2007). The NICE guidance presented in this section will be revisited and considered in relation to the main findings of this rapid review later in the discussion section of this report (Section 3).

The NICE 2021 (NG210) guideline focuses on the prevention and non-surgical management of pelvic floor dysfunction, and cites urinary incontinence, faecal incontinence and pelvic floor prolapse as the three most common and definable symptoms of this condition (NICE, 2021a). The guidance document reports that being over the age of 30 when giving birth, and having previous childbirths are risk factors for pelvic floor dysfunction. Labour-related risk factors include assisted vaginal births (forceps or vacuum), occipito-posterior births (where the baby is lying face-up), an active second stage of labour lasting more than 1 hour, and trauma/injury to the anal sphincter during childbirth (NICE, 2021a). While the issue of incontinence is a significant part of pelvic floor dysfunction, the guideline provides a broader approach to managing these issues. The guidance emphasises prevention by reducing modifiable risk factors which can contribute to incontinence and recommends thorough clinical assessment to determine the type and severity of incontinence (NICE, 2021a).

NICE recommends pelvic floor muscle training (PFMT) for prenatal and postnatal women to prevent symptoms of pelvic floor dysfunction (NICE, 2021a). NICE has recommended PFMT as a first-line treatment for urinary incontinence since 2006 and points to the clinical effectiveness and cost-effectiveness of PFMT as a preventative measure. The 2021 NICE guidance recommends that PFMT should be supervised by a physiotherapist. In the NHS Long Term Plan, physiotherapy was reported as the most cost-effective intervention for preventing and treating mild to moderate incontinence and prolapse (NHS, 2019). The evidence review (NICE, 2012b) supporting the NICE guidance found that PFMT improves several symptoms of pelvic floor dysfunction (pelvic organ prolapse, stress and mixed urinary incontinence, and faecal incontinence with coexisting pelvic organ prolapse).

In France, all postnatal women receive pelvic floor rehabilitation. NICE guidance states that there is not enough strong evidence on the cost-effectiveness of this model for adoption in the UK and makes a recommendation for research on whether universal postnatal PFMT is effective in preventing pelvic floor dysfunction. NICE guidance states that antenatal supervised PFMT is likely to be cost-effective for some pregnant women, in particular women in the groups identified at higher risk of developing pelvic floor dysfunction. The guidance recommends PFMT as an option as it is likely to be cost-effective for some women in these groups. The NICE urinary incontinence quality standard states that pregnant women with stress urinary incontinence or mixed urinary incontinence should be offered a programme of supervised PFMT for at least three months (NICE 2021c). The same recommendation of a three-month supervised programme should also be offered from week 20 of pregnancy to women who have a first-degree relative with pelvic floor dysfunction (NICE 2021a).

Based on the findings of the NICE evidence review, the committee’s discussion of the evidence recommended that all women should be encouraged to do pelvic floor muscle exercises (NICE, 2021b). The 2021 NICE guidance also takes into account recommendations made by the Independent Medicines and Medical Devices Safety Review, which emphasises the life-course model, recommending that pelvic floor education should be encouraged in antenatal classes and in schools, where appropriate (UK Government, 2020). Despite limited evidence on long-term effectiveness, in the committee’s experience continuing with PFMT is key for continued prevention of symptoms, and they agree that low long-term adherence is likely to explain the limited evidence for long-term effectiveness. Recognising these problems with adherence, the committee agree that women should be encouraged to continue PFMT throughout their life. One study that informed the 2021 NICE guidance showed that PFMT significantly reduced the number of post-menopausal women developing urinary incontinence. From this study, NICE recommends further research into whether PFMT is effective in preventing pelvic floor dysfunction for older women (aged 65 and over), and women in the perimenopausal or postmenopausal phases.

The NICE 2021 guidance also highlights that the effectiveness of intravaginal devices when combined with PFMT is still unclear based on current evidence and consequently the committee made a recommendation for research on the effectiveness of vaginal devices (NICE, 2021a).

The NICE 2007 guidance (CG49) emphasises the importance of PFMT as a first-line treatment for obstetric-related faecal incontinence, which is a debilitating condition that may present early after giving birth (NICE, 2007). The guidance highlights that previous birth trauma is a significant cause of faecal incontinence in later life and advocates the value of preventative measures that will benefit both younger and older individuals (NICE, 2007).

NICE advocates that early intervention in the postpartum period may decrease the risk of delayed-onset faecal incontinence in women; however, evidence is lacking on whether prenatal interventions (before obstetric trauma or injury) can provide a protective role in preventing faecal incontinence (NICE, 2007).

2.1 Overview of the Evidence Base

This rapid review aims to complement the NICE 2021 guidance (NG210) on the prevention and non-surgical management of pelvic floor dysfunction, and the NICE 2007 guidance (CG49) on the management of faecal incontinence in adults which was summarised in section 1.4 of this rapid review report. The rapid review findings reported in this section (Section 2) will be considered in relation to the NICE guidance in the discussion section of this report (Section 3). Evidence of clinical effectiveness from systematic reviews studies is presented in Section 2.2, followed by cost-effectiveness evidence from economic evaluations in Section 2.3.

The methods and eligibility criteria used for conducting the review are presented in Section 5. The rapid review search strategy is presented in Appendix 1. After the removal of duplicates, the database searches identified 3,383 references (see Figure 1 in Section 6.1 for the PRISMA diagram). Following title and abstract screening, 56 papers were retrieved for full text screening. Twenty-three studies were included in this rapid review: three economic evaluations (Bick et al., 2017; Brennen et al., 2021; NICE, 2021), and 20 systematic reviews of clinical effectiveness, of which two were reviews of existing reviews (Ryhtä et al., 2023; Sananès et al., 2023). The overlap of primary studies within this rapid review is low at <5%, as shown in the diagram in Appendix 4. However, this assessment of overlap did not include the two reviews of existing reviews (Sananès et al., 2023; Ryhtä et al., 2023). It is important to note that one of the reviews presented in the review of existing Cochrane systematic reviews (Sananès et al., 2023) also included one of the systematic reviews included in this rapid review (Woodley et al., 2020). Of the nine systematic reviews included in the second review of existing reviews (Ryhtä et al., 2023), five are included in this rapid review.

• Download figure
• Open in new tab

Figure 1. PRISMA 2020 flow diagram of included records (Page et al., 2021)

The 20 systematic reviews included in this rapid review were conducted by authors in the UK (Oblasser et al., 2015; Wagg & Bunn, 2007), Australia (Haddow et al., 2005), Canada (Davenport et al., 2018; Harvey, 2003), New Zealand (Woodley et al., 2020), Belgium (Van Kampen et al., 2015), Switzerland (Sananès et al. 2023), Spain (Perales et al., 2016; Zhang et al., 2023), Finland (Ryhtä et al., 2023), Poland (Milka et al., 2023), Columbia (Mantilla Toloza et al., 2024), China (Chen et al., 2022), Egypt (Abdelhakim et al., 2020), Japan (Shinozaki et al., 2023), Iran (Khorasani et al., 2020), and Brazil (Lemos et al., 2008; Schreiner et al., 2018; Santos et al., 2024). All of the systematic reviews reported on the impact of interventions to reduce pregnancy or birth-related incontinence, with some reviews assessing the effectiveness of multiple interventions. Of the 20 systematic reviews of clinical effectiveness included in this rapid review, eight systematic reviews reported on the effectiveness of PFMT/pelvic floor muscle exercise, four explored mixed exercise interventions, five reviews assessed prenatal perineal massage, one reported on birthing position, and three assessed vaginal devices.

Three economic evaluation studies were included as part of this rapid review. The first study was conducted in England and Wales and included two economic evaluations, a cost- consequence analysis and a cost-effectiveness analysis comparing an upright birthing position with a lying down birthing position (Bick et al., 2017). The second economic evaluation was a cost-effectiveness analysis based on a systematic review of different models of supervised pelvic floor muscle training (PFMT) and was conducted by a team of researchers from Australia (Brennen et al., 2021). The third economic evaluation was a model-based cost-utility analysis of supervised prenatal PFMT utilising existing data from two studies (both reporting on the same supervised PFMT intervention at two separate time points) conducted as part of 2021 NICE guidance (NICE, 2021b).

2.2 Effectiveness of interventions to prevent incontinence and birth trauma outcomes

A summary of the findings from the 20 systematic review papers is presented with a specific focus on incontinence outcomes. Intermediate outcomes reported in the systematic reviews that can impact on/or are impacted by incontinence such as birth trauma outcomes, pelvic floor strength, quality of life, and adverse outcomes (e.g., perineal pain, vaginitis) are also presented. The outcomes reported in each systematic review are presented in Table 2 under Section 6.2 of this report. Where possible, information on the type of birthing mode has been presented if information was available in the systematic review papers (Table 2, Section 6.2). A graphical representation of the overlap of primary studies across the systematic reviews is presented in Appendix 4 (Section 8.4). This ‘GROOVE’ assessment of overlap (Bracchiglione et al., 2022) excluded the two reviews of existing reviews as they did not review primary studies. The GROOVE exercise reported a slight overlap (3.5%) across 18 systematic reviews included in this study (Appendix 4, Section 8.4).

The following sub-sections are divided into intervention types reported in the identified SR papers and include the following: pelvic floor muscle training/exercise, mixed exercise programmes, prenatal perineal massage, and birthing position and vaginal devices.

2.3 Cost-effectiveness of interventions to prevent incontinence

All three of the included economic evaluations were deemed to be of high quality when appraised using the JBI checklist for economic evaluations (Joanna Briggs Institute, 2017a).

The first economic evaluation reports a within-trial cost-consequence analysis and cost- effectiveness analysis of a multi-centre randomised controlled trial to assess whether a policy of adopting an ‘upright position’ throughout second-stage labour increases the incidence of spontaneous vaginal delivery compared with a policy of adopting a ‘lying-down’ position among nulliparous women with epidural analgesia (Bick et al., 2017). Despite not being a directly relevant intervention to prevent incontinence, this economic evaluation of birthing positions collected short-term (3 months follow-up) and longer-term (1 year follow- up) outcomes of urinary and faecal incontinence following each delivery mode as part of the cost-consequence analysis. The analysis was undertaken from an NHS perspective over a one-year time horizon (Bick et al., 2017). Costs were health service utilisation costs presented in British pounds sterling for cost year 2013/14 (Table 3, Section 6.2).

The cost-effectiveness analysis of the delivery modes calculated the cost per additional case of spontaneous vaginal delivery where the lying down position was used as the comparator in the incremental cost-effectiveness ratio (ICER) calculation. The reported ICER (95% CI) was £722 (–£2968 to £6358) per additional case of spontaneous vaginal delivery for birthing in the upright position versus lying down (Bick et al., 2017). Incontinence was not considered as an outcome in this cost-effectiveness analysis. Therefore, priority was given to the presentation of the findings of the cost-consequence analysis as it reported on short and long-term incontinence outcomes following childbirth.

The trial demonstrated a statistically significant difference (adjusted risk ratio 0.86, 95% CI 0.78 to 0.94) in the rate of spontaneous vaginal deliveries between the groups with 41.1% of women who adopted a ‘lying down’ position achieving a spontaneous vaginal delivery, compared with 35.2% of women who remained in an upright position (Bick et al., 2017).

At 3 month follow-up, birthing position demonstrated no statistically significant difference on the prevalence of urinary incontinence (49.2% upright position, 49.4% lying down position; RR 0.99 (0.88 to 1.13)). However, a statistically significant difference in prevalence of faecal incontinence (defined as no bowel control and/or soiling) was observed at 3-months (11.5% upright position, 14.2% lying down position; RR 0.81 (0.59 to 1.12)). At 12 month follow-up, there was no statistically significant difference in urinary incontinence (as measured by the International Consultation on Incontinence Questionnaire-Urinary Incontinence) between birthing positions (Median [IQR]: 0 [0-4] upright position, 0 [0-4] lying down position; Median difference 0 [0 to 0]). No statistically significant difference was observed in prevalence of faecal incontinence between birthing position at this follow up (3.2% upright position, 3.2% lying down position; RR 1.02 (0.51 to 2.02)). Regarding immediate costs, the lying down position was associated with lower NHS resource use costs when giving birth at hospital, with a mean cost difference of £59 (95% CI £6 to £111) between groups. These lower resource use costs were due to the higher proportion of spontaneous vaginal deliveries in the lying down group compared with the upright position group. There was no significant difference in NHS resource use costs between groups for mothers and their infants at 12- months. Results of the cost-consequence analysis concluded that birthing position had little impact on the prevalence of urinary incontinence in the short-term, and no impact on prevalence in urinary or faecal incontinence at 12 months. A small statistically significant difference in prevalence of faecal incontinence was observed at 3 months.

The second economic evaluation was a cost-effectiveness analysis using data from a Cochrane systematic review of three different clinically effective models of pelvic floor muscle training (PFMT) for the prevention or treatment of postpartum incontinence (Brennan et al., 2021). Model 1 consisted of prenatal individually supervised PFMT to prevent urinary incontinence UI, model 2 was prenatal group-based PFMT to prevent or treat UI, and model 3 was postnatal individually supervised PFMT to treat urinary incontinence and prevent faecal incontinence. The economic evaluation was undertaken from the health service, consumer and societal perspectives and costs were presented in Australian dollars for cost year 2019 (Table 3, Section 6.2). The analysis presented the incremental cost of curing or preventing one case of incontinence. The incremental cost per case of urinary incontinence prevented or cured was $768 and $1,970 for model 1 and model 3, respectively. Model 2 (group-based PFMT) produced the greatest saving in costs (with $14.53 per case of urinary incontinence prevented or cured if eight women attended a session of group-based PFMT). For model 3, the cost to prevent or cure one case of faecal incontinence was $2,784 (Brennen et al., 2021). The authors concluded that group-based PFMT was found to be more cost-effective than individually supervised PFMT for treating women with postnatal incontinence (Brennen et al., 2021). However, it must be noted that the analysis did not compare cost-effectiveness of the intervention against a willingness to pay threshold making the results difficult to interpret by decision makers.

The third economic evaluation was a cost-utility analysis utilising a decision analytic Markov model of supervised prenatal PFMT and was conducted as part of the 2021 NICE guidance on the prevention and non-surgical management of pelvic floor dysfunction (NICE, 2021b). The proportion of women who would develop urinary incontinence over time in the absence of preventative PFMT was estimated using data from two studies reporting on the same intervention at different follow-up time-points, Reilly (2002), and Agur (2008), and the UR- CHOICE prediction model. The cost-utility analysis was conducted from an NHS and Personal Social Services perspective over a lifetime horizon. The cost of a PFMT session and the monthly health resource costs of urinary incontinence were presented in British Pounds Sterling for the cost year 2020. The cost-utility analysis found the intervention to be cost-effective compared to no intervention in a population with a 50% risk of pelvic floor dysfunction (NICE, 2021b). Total costs were greater in the group receiving the intervention (£827) than the group receiving no intervention (£539). The difference in costs was driven by the cost of administering the intervention. Urinary Incontinence management costs were similar across both groups, being slightly more costly in the group receiving no intervention (£539) than the group who received it (£507). The intervention group gained more QALYs (20.977) than the group not receiving the intervention (20.952). The corresponding incremental cost-effectiveness ratio (ICER) for the intervention group was £11,432 per QALY gained (NICE, 2021b). This indicates that the intervention is cost-effective at any cost- effectiveness threshold greater than £11,000. NICE typically recommends implementing interventions that have a cost per QALY between a threshold of £20,000 and £30,000.

3.1 Summary of the findings

3.2 Strengths and limitations of the available evidence

There is a dearth of evidence on the costs and cost-effectiveness of interventions to prevent incontinence resulting from birth trauma. Only three economic evaluations were identified in this rapid review; two of which assessed PFMT interventions (which were directly relevant to the rapid review question), and the other was an economic evaluation of birthing positions (an intervention not designed to prevent incontinence). The review failed to identify evidence on costs or cost-effectiveness for other types of interventions such as wider exercise programs, prenatal perineal massage, vaginal devices, or other intervention types.

There are challenges to evaluating the cost-effectiveness of interventions in this area, while QALYs are a valuable tool for measuring health-related quality of life in many contexts, their application to conditions like incontinence presents unique challenges. The impact of incontinence on health-related quality of life may vary across different population groups due to factors such as age and disability, as well as cultural and socioeconomic factors. In addition, due to the absence of a standard health outcome to incorporate within cost- effectiveness analyses of interventions to prevent incontinence, results of cost-effectiveness analyses in this area are difficult to interpret by decision makers due to the lack of a willingness to pay threshold.

There were a number of limitations in the included studies. Four of the systematic reviews were deemed to be of low quality when critically appraised using the JBI Checklist for Systematic Reviews and Research. Another limitation of the available evidence was a lack of information in the included systematic review papers on sample variables such as age, birthing delivery method and smoking status which restricted subgroup analyses in this review.

Clinical effectiveness was typically assessed over short term time horizons in most of the identified studies. The NICE manual for conducting health technology evaluations states a time horizon long enough to reflect all important differences in costs or outcomes should be used (National Institute for Health and Care Excellence, 2022). Given the potential for long- term impacts of incontinence, short time horizons may omit relevant costs or outcomes.

3.3 Strengths and limitations of this Rapid Review

This rapid review undertook thorough literature searches with no limit on search dates, using a well-developed search strategy and robust methodology. The searches aimed to identify evidence on the costs, cost-effectiveness and clinical effectiveness of any intervention type that aims to prevent incontinence resulting from childbirth. Despite the lack of available evidence on the cost-effectiveness of interventions to prevent incontinence due to birth trauma, this rapid review was successful in identifying a large evidence base on the clinical effectiveness of PFMT and exercise, although there was less evidence on prenatal perineal massage, birthing position and vaginal device interventions.

This review identified 20 systematic reviews assessing the clinical effectiveness of interventions. We acknowledge that by limiting the search for effectiveness evidence to systematic reviews only, there may be primary studies of additional intervention types to improve incontinence following childbirth that have not been represented in the identified systematic reviews. The systematic reviews included in this rapid review focused on specific intervention types such as PFMT, exercise and prenatal perineal massage. Only one of the included reviews evaluated ‘any type’ of intervention, this was a review of existing Cochrane systematic reviews of RCTs of any type of antenatal, intrapartum and postpartum interventions for preventing postpartum urinary and faecal incontinence (Sananès et al. 2023). However, there may be non-Cochrane systematic reviews of additional interventions that have not been captured in this review of reviews. In addition, there may also be primary studies of additional intervention types published since the date of the searches of the included reviews.

While reviews of existing reviews are valuable in synthesising evidence from multiple systematic reviews, including multiple reviews that include the same primary studies can lead to redundant information and inflated effect sizes. In addition, overlapping studies may differ in their methodological quality, which can increase the risk of bias. Different inclusion criteria across the different reviews make it difficult to compare and pool results. This rapid review utilised the Graphical Representation of Overlap for OVErviews (GROOVE) tool to assess the overlap of primary studies across the systematic review papers (Bracchiglione et al., 2022). The overlap was calculated at 3.5%, indicating ‘slight’ overlap across the studies (overlap cut-point grouping: <5% slight, 10% to <15% moderate, 10% to <15% high, >15% very high). Nevertheless, it must be acknowledged that the assessment of overlap conducted using the GROOVE tool only included 18 of the systematic reviews included in this rapid review. The two reviews of existing reviews were excluded from the assessment as they did not include a review of primary studies and therefore, it must be acknowledged that the degree of overlap of evidence may be greater than reported.

Due to the low number of economic studies in this topic area, the review was supplemented by targeted searches to present the economic case for investing in interventions that have been evidenced in terms of their clinical effectiveness. This involved a separate targeted search to identify the most useful studies reporting economic burden in this topic area (section 1.3). Nevertheless, we did not identify studies that directly assess the economic burden of incontinence directly related to perineal trauma in the UK.

This rapid review was limited to economic evaluations and systematic reviews of clinical effectiveness and therefore omits important qualitative evidence of women’s experiences and the acceptability of interventions to prevent incontinence. Consequently, a synthesis of qualitative evidence is needed in parallel to the evidence on the clinical effectiveness and cost effectiveness evidence in order to make recommendations for policy and practice.

3.4 Implications for policy and practice

Despite a paucity of economic evaluations assessing the cost-effectiveness of interventions for the prevention of incontinence, the substantial economic burden of incontinence on the NHS necessitates investment in clinically effective, preventative options. A large evidence base exists on the effectiveness of PFMT and exercise interventions to prevent incontinence due to childbirth, and the findings of this review present the case for investing in interventions that have been found to be clinically effective. This report synthesised evidence from twelve systematic reviews on the effectiveness of pelvic floor muscle training and exercise. However, the description, delivery and dosage of prescribed exercises were heterogenous across the reviews. While NICE emphasises the importance of ongoing pelvic floor muscle training for sustained benefits, low adherence rates may contribute to the limited evidence for long-term effectiveness. Consequently, assessments on the effectiveness of unsupervised PFMT and how best to support ongoing adherence such as the utilisation of e-health platforms are needed. It must also be noted that the provision of ongoing supervised pelvic floor muscle training will require additional resource allocation for staff time. Moreover, future recommendations for policy and practice must also consider qualitative findings of women’s experiences and the acceptability and feasibility of rolling out interventions for the prevention of incontinence which play an important role in the adherence and maintenance of PFMT.

3.5 Implications for future research

Regarding clinical effectiveness, PFMT and PFME were well represented in the evidence base identified in our rapid review. Other interventions, such as prenatal perineal massage and other therapeutic interventions, were less represented in this rapid review, especially for faecal incontinence outcomes, indicating a potential gap in the evidence base. Our rapid review findings are in-line with the recommendation for research on the effectiveness of vaginal devices made by NICE, our rapid review identified two systematic reviews reporting on the effectiveness of vaginal devices for existing incontinence, but neither of the reviews reported on the prevention of incontinence. We also acknowledge that by limiting the search for effectiveness evidence to systematic reviews only, there may be primary studies available assessing additional intervention types to improve incontinence following childbirth that have not been included in our rapid review.

A significant evidence gap exists regarding the cost-effectiveness of interventions aimed at preventing incontinence resulting from birth trauma. This rapid review indicates the necessity for economic evaluations to assess the value for money of these interventions. By quantifying the costs and benefits of different approaches, researchers can provide crucial information to policy makers to inform resource allocation decisions. Economic evaluations are required to assess the cost-effectiveness of interventions found to be clinically effective in the existing systematic reviews identified in this rapid review. The model-based cost-utility analysis undertaken by NICE is an example of this, utilising data from two previously published randomised controlled trials assessing the same intervention at different follow-up periods (NICE, 2021b).

Incontinence is a long-term burden as pregnancy and childbirth can weaken the pelvic floor, making women more susceptible to incontinence in later life (NICE, 2021a). Menopause often exacerbates these issues due to hormonal changes and by further weakening the pelvic floor muscles (Menezes et al., 2010). Obstetric trauma from vaginal delivery resulting in irreversible traumatic lesions to the urinary continence system is also a known link to incontinence in later life (Fritel et al., 2012). The evidence review conducted as part of the NICE 2021 guidance only identified one study on PFMT for women over 60 (not included in this rapid review as it did not meet the rapid review eligibility criteria) and made recommendations for future research in this area (NICE, 2021a). In their 2021 guidance, NICE also draws attention to the limited evidence on the long-term effectiveness of PFMT interventions (NICE, 2021a).

To fully understand the effectiveness and cost-effectiveness of interventions to prevent incontinence resulting from birth trauma, future research should adopt longer study time horizons to allow for the assessment of potential long-term impacts, such as the influence of interventions on incontinence during menopause. Exploration of outcomes over longer time horizons will enable researchers to gain valuable insights into any sustained benefits of interventions. Large scale studies of potentially inexpensive interventions are needed that better capture the wider societal costs and implications of the lifetime burden of incontinence. The use of model-based economic analyses can facilitate longer time horizons beyond that typically used in clinical trials through the extrapolation of cost and outcomes data. The model-based cost-utility analysis undertaken by NICE included a lifetime horizon in its analysis, achieved through simulating the data from two previously published randomised controlled trials (NICE, 2021b).